Cargando…

Serine-/Cysteine-Based sp(2)-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma

[Image: see text] Glycolipids with TLR4 agonistic properties can serve either as therapeutic agents or as vaccine adjuvants by stimulating the development of proinflammatory responses. Translating them to the clinical setting is hampered by synthetic difficulties, the lack of stability in biological...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Cuesta, Manuel, Lai, Alan Chuan-Ying, Chi, Po-Yu, Hsu, I-Ling, Liu, Nien-Tzu, Wu, Ko-Chien, García Fernández, José M., Chang, Ya-Jen, Ortiz Mellet, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108363/ https://www.ncbi.nlm.nih.gov/pubmed/36958376 http://dx.doi.org/10.1021/acs.jmedchem.2c01948

Ejemplares similares

Synthetic glycan-based TLR4 agonists targeting caspase-4/11 for the development of adjuvants and immunotherapeutics
por: Adanitsch, Florian, et al.
Publicado: (2018)

Lipid A Mimetics Based on Unnatural Disaccharide Scaffold as Potent TLR4 Agonists for Prospective Immunotherapeutics and Adjuvants
por: Strobl, Sebastian, et al.
Publicado: (2022)

TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
por: Owen, Allison M., et al.
Publicado: (2021)

Functional characterization of the alanine-serine-cysteine exchanger of Carnobacterium sp AT7
por: Bartoccioni, Paola, et al.
Publicado: (2019)

Local immune and microbiological responses to mucosal administration of a Liposome-TLR agonist immunotherapeutic in dogs
por: Wheat, William, et al.
Publicado: (2019)

Development of N-Acetylated Dipalmitoyl-S-Glyceryl Cysteine Analogs as Efficient TLR2/TLR6 Agonists
por: Zhou, Yang, et al.
Publicado: (2019)

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
por: Luchner, Marina, et al.
Publicado: (2021)

Vaccine adjuvants as potential cancer immunotherapeutics
por: Temizoz, Burcu, et al.
Publicado: (2016)

Immunotherapeutic Potential of Mollusk Hemocyanins in Combination with Human Vaccine Adjuvants in Murine Models of Oral Cancer
por: Mora Román, Juan José, et al.
Publicado: (2019)

A novel defined TLR3 agonist as an effective vaccine adjuvant
por: Ko, Kwang Hyun, et al.
Publicado: (2023)

An archaeal ADP-dependent serine kinase involved in cysteine biosynthesis and serine metabolism
por: Makino, Yuki, et al.
Publicado: (2016)

BBIQ, a pure TLR7 agonist, is an effective influenza vaccine adjuvant
por: Kaushik, Deepender, et al.
Publicado: (2020)

Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy
por: Bhatnagar, Shubhmita, et al.
Publicado: (2022)

The Nϵ‐Rule for Serine, but Not Cysteine Catalytic Triads
por: Czapinska, Honorata, et al.
Publicado: (2022)

Differential Adjuvant Activities of TLR7 and TLR9 Agonists Inversely Correlate with Nitric Oxide and PGE(2) Production
por: Lee, Jinhee, et al.
Publicado: (2015)

Quantifying tetrahedral adduct formation and stabilization in the cysteine and the serine proteases
por: Cleary, Jennifer A., et al.
Publicado: (2015)

The TLR7 agonist imiquimod as an adjuvant for radiotherapy-elicited in situ vaccination against breast cancer
por: Demaria, Sandra, et al.
Publicado: (2013)

Evaluation of TLR Agonists as Potential Mucosal Adjuvants for HIV gp140 and Tetanus Toxoid in Mice
por: Buffa, Viviana, et al.
Publicado: (2012)

Molecular Signatures of a TLR4 Agonist-Adjuvanted HIV-1 Vaccine Candidate in Humans
por: Anderson, Jenna, et al.
Publicado: (2018)

A TLR9 agonist synergistically enhances protective immunity induced by an Alum-adjuvanted H7N9 inactivated whole-virion vaccine
por: Tzeng, Tsai-Teng, et al.
Publicado: (2023)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
por: Shanmugam, Arulkumaran, et al.
Publicado: (2012)

Molecular and Cellular Response Profiles Induced by the TLR4 Agonist-Based Adjuvant Glucopyranosyl Lipid A
por: Lambert, Stacie L., et al.
Publicado: (2012)

Roles of quaternary structure and cysteine residues in the activity of human serine racemase
por: Wang, Wei, et al.
Publicado: (2011)

Cysteine biosynthesis in Lactobacillus casei: identification and characterization of a serine acetyltransferase
por: Bogicevic, Biljana, et al.
Publicado: (2016)

Coumarin as a structural component of substrates and probes for serine and cysteine proteases
por: Breidenbach, Julian, et al.
Publicado: (2020)

Plant Serpins: Potential Inhibitors of Serine and Cysteine Proteases with Multiple Functions
por: Ferreira, Monaliza Macêdo, et al.
Publicado: (2023)

Exploring the Immunotherapeutic Potential of Oleocanthal against Murine Cutaneous Leishmaniasis
por: Karampetsou, Kalliopi, et al.
Publicado: (2022)

An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants
por: Kayesh, Mohammad Enamul Hoque, et al.
Publicado: (2021)

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors
por: Albershardt, Tina C., et al.
Publicado: (2020)

Using distinct molecular signatures of human monocytes and dendritic cells to predict adjuvant activity and pyrogenicity of TLR agonists
por: Kamgang, Richard Kenmoe, et al.
Publicado: (2008)

A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93
por: Orr, Mark T., et al.
Publicado: (2014)

New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses
por: Gutjahr, Alice, et al.
Publicado: (2020)

New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
por: Romerio, Alessio, et al.
Publicado: (2023)

Characterization of a Family of Novel Cysteine- Serine-Rich Nuclear Proteins (CSRNP)
por: Gingras, Sébastien, et al.
Publicado: (2007)

Wnt3 Is Lipidated at Conserved Cysteine and Serine Residues in Zebrafish Neural Tissue
por: Dhasmana, Divya, et al.
Publicado: (2021)

Surface cysteine to serine substitutions in IL-18 reduce aggregation and enhance activity
por: Saetang, Jirakrit, et al.
Publicado: (2022)

Immunotherapeutic and Targeted Approaches in Multiple Myeloma
por: Nadeem, Omar, et al.
Publicado: (2020)

Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models
por: Zhang, Weidong, et al.
Publicado: (2018)

Deoxyguanosine is a TLR7 agonist
por: Davenne, Tamara, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tr4mdbsv6h35229ljjhv1m0o0k